Dabrafenib trials for Lung cancer

All Dabrafenib trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Dabrafenib for Lung cancer

• DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
  NCT07440290 · Phase: Phase 2, Phase 3 · Ages: 1 Year and older · Sex: All (male and female) · 27 locations
• Dabrafenib and/or Trametinib Rollover Study
  NCT03340506 · Phase: Phase 4 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 33 locations
• ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
  NCT06532149 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: Male · 1 location

Common questions

How many trials study Dabrafenib for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.